The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
Abstract
Evans syndrome (ES) is a rare severe autoimmune disorder characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia. In most cases, the underlying cause is unknown. We sought to identify genetic defects in pediatric ES (pES), based on a hypothesis of strong genetic determinism. In a national, prospective cohort of 203 patients with early-onset ES (median [range] age at last follow-up: 16.3 years ([1.2-41.0 years]) initiated in 2004, 80 nonselected consecutive individuals underwent genetic testing. The clinical data were analyzed as a function of the genetic findings. Fifty-two patients (65%) received a genetic diagnosis (the M+ group): 49 carried germline mutations and 3 carried somatic variants. Thirty-two (40%) had pathogenic mutations in 1 of 9 genes known to be involved in primary immunodeficiencies (TNFRSF6, CTLA4, STAT3, PIK3CD, CBL, ADAR1, LRBA, RAG1, and KRAS), whereas 20 patients (25%) carried probable pathogenic variants in 16 genes that had not previously been reported in the context of autoimmune disease. Lastly, no genetic abnormalities were found in the remaining 28 patients (35%, the M− group). The M+ group displayed more severe disease than the M− group, with a greater frequency of additional immunopathologic manifestations and a greater median number of lines of treatment. Six patients (all from the M+ group) died during the study. In conclusion, pES was potentially genetically determined in at least 65% of cases. Systematic, wide-ranging genetic screening should be offered in pES; the genetic findings have prognostic significance and may guide the choice of a targeted treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions
Ombrello, M. J., Remmers, E. F., Sun, G., Freeman, A. F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T. D., Baxendale, R. W., Martins, M. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1102140 · Cited by 425
Zhou, Q., Lee, G.-S., Brady, J., Datta, S., Katan, M., Sheikh, A., Martins, M. S., Bunney, T. D., Santich, B. H., Moir, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.006 · Cited by 374
Chun, S., Casparino, A., Patsopoulos, N. A., Croteau-Chonka, D. C., Raby, B. A., De Jager, P. L., Sunyaev, S. R., & Cotsapas, C. (2017) · Nature Genetics · doi:10.1038/ng.3795 · Cited by 259
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency
Boutboul, D., Kuehn, H. S., Van de Wyngaert, Z., Niemela, J. E., Callebaut, I., Stoddard, J., Lenoir, C., Barlogis, V., Farnarier, C., Vely, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98164 · Cited by 169
Self-citationNovel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa
Neves, J. F., Doffinger, R., Barcena-Morales, G., Martins, C., Papapietro, O., Plagnol, V., Curtis, J., Martins, M., Kumararatne, D., Cordeiro, A. I., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02863 · Cited by 79
PLC-γ2 is essential for formation and maintenance of memory B cells
Hikida, M., Casola, S., Takahashi, N., Kaji, T., Takemori, T., Rajewsky, K., & Kurosaki, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082100 · Cited by 73
Cited by
Tangye, S. G., Al-Herz, W., Bousfiha, A., Cunningham-Rundles, C., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Oksenhendler, E., Picard, C., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01289-3 · Cited by 1,156
Self-citationPharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
Metadata
- Authors
- Hadjadj, J., Aladjidi, N., Fernandes, H., Leverger, G., Magérus-Chatinet, A., Mazerolles, F., Stolzenberg, M.-C., Jacques, S., Picard, C., Rosain, J., Fourrage, C., Hanein, S., Zarhrate, M., Pasquet, M., Abou Chahla, W., Barlogis, V., Bertrand, Y., Pellier, I., Colomb Bottollier, E., Fouyssac, F., Blouin, P., Thomas, C., Cheikh, N., Dore, E., Pondarre, C., Plantaz, D., Jeziorski, E., Millot, F., Garcelon, N., Ducassou, S., Perel, Y., Leblanc, T., Neven, B., Fischer, A., & Rieux-Laucat, F.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2019-07-04
- Volume
- 134
- Issue
- 1
- Pages
- 9-21
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2927192868
- Cited by
- 159
- References
- 7
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. https://app.cochat.ai/papers/10.1182/blood-2018-11-887141
- The paper
- Hadjadj, J., Aladjidi, N., Fernandes, H., Leverger, G., Magérus-Chatinet, A., Mazerolles, F., Stolzenberg, M.-C., Jacques, S., Picard, C., Rosain, J., Fourrage, C., Hanein, S., Zarhrate, M., Pasquet, M., Abou Chahla, W., Barlogis, V., Bertrand, Y., Pellier, I., Colomb Bottollier, E., . . . Rieux-Laucat, F. (2019). Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. https://doi.org/10.1182/blood-2018-11-887141
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.